AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca uncertain tax position provision — Transfer pricing contingencies ($M) ($M)
Form 20-F Note 5 — Taxation
Latest, FY2025
120
Period ended Dec 31, 2025
Change on a year earlier
-68.7%
384 in FY2024
History
6 years
Since FY2020
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Uncertain tax position provision — Transfer pricing contingencies ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 120 | -68.7% | Form 20-F FY2025 Annual Report ↗ |
| FY2024 | Dec 31, 2024 | 384 | -4.2% | Form 20-F FY2025 Annual Report ↗ |
| FY2023 | Dec 31, 2023 | 401 | +54.2% | Form 20-F FY2024 Annual Report ↗ |
| FY2022 | Dec 31, 2022 | 260 | +237.7% | Form 20-F FY2024 Annual Report ↗ |
| FY2021 | Dec 31, 2021 | 77 | -73.2% | Form 20-F FY2023 Annual Report ↗ |
| FY2020 | Dec 31, 2020 | 287 | – | Form 20-F FY2023 Annual Report ↗ |
Cite this data
StockData. (2026). AstraZeneca Uncertain tax position provision — Transfer pricing contingencies ($M) ($M), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/tax_contingency_tp
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.